obtained
amsterdam
dphe6
website
RESULTS
tedesco
them
human
90Y
VJ
specificity
item
liu
represent
propertie
title
BE
several
there
antigen
emitter
men
drug
aca
critical
claesener
hricak
database
ability
240
statistic
linear
tolerability
category
affect
millicurie
included
calibrator
very
synthesi
surgery
utilized
mol
peptide
analysi
mice
nanomedicine
inclusion
review
functional
bloi
such
guo
retention
ahx
ligand
route
KEYWORDS
releasing
umi
exclusion
flow
124I
vivo
radiotracer
acces
stage
include
large
camera
5093
209
pangribowo
soerensen
high
model
αvβ5
observed
overexpressed
pellegrini
eastham
act
yordanova
wang
profile
destructive
worse
mueller
FS
valuable
manuscript
viabilitie
laversanne
RM2
detailed
hour
damaging
gastrointestinal
okarvi
global
diagnose
dalm
searching
med
tian
same
publication
sandler
site
secreted
highest
conducted
tabulated
information
front
made
characteristic
787
FDA
tolerated
point
countrie
volume
journal
ed
analog
getting
2017
syabrina
indonesian
2014
intestine
299
preferred
bearing
compound
min
particulate
integrin
produced
effort
reynold
positron
faculty
WHO
pelvic
medical
kind
gonen
vorobyova
sensitivity
method
term
presence
230
most
however
indonesia
90231
bivalent
cai
neobomb1
krieger
293
dan
evaluation
following
mci
showed
sar11
janota
2447
retrospective
detected
KD
obat
growing
screening
compared
combined
matched
another
side
overview
325
science
developing
above
development
text
rosilawati
murni
leu
VCN
injection
scardino
bode
protocol
identify
determine
figure
resistant
massspeg2
other
GN
had
prolonged
miao
collection
like
PT
organization
disappeared
riskesda
abnormal
1919
nurmaya82
medicine
worldwile
monomer
effendi
enhanced
mean
liver
heart
than
worldwide
baum
vβ3
minimal
emitting
visible
examination
affibody
schibli
alpha
JA
SES
muzakkir
PEG2
continue
focused
481
amount
safety
MD
contribution
department
similar
common
open
penggunaan
α5β1
inf
modification
visualized
bia
evidenced
REFERENCES
paper
lymphatic
area
disintegrin
different
receptor
material
berger
nock
written
visualization
soepra
name
excellent
tetradecapeptide
terapi
orlova
reactor
prostate
low
captured
publicly
throughout
apply
miller
pancrea
concept
eppard
AMA
WA
plasma
cell
sep
malignancy
absence
www
bandara
yung
characterized
promising
computed
radiofarmaka
heinzel
radioligand
entire
PIP
markland
their
METHODOLOGY
declared
toujier
jemal
binding
micropet
after
TJS
INTRODUCTION
location
gamma
clearly
salsabilah
quality
mortality
111in
emission
applied
table
body
kaloudi
410
oncology
MW
focusing
specific
writing
biodistribution
neobomb
173
still
PRISMA
activity
DISCUSSION
GRPR
adverse
last
mild
magnetic
molecule
antibodie
photon
chemistry
niu
older
membrane
mikołajczak
reported
long
diebolder
tumor
imaging
english
pharmaceutic
ferlay
nhet13
SCID
186re
PEG3RM26
show
aim
well
esophageal
chernov
data
HAV
good
qualitative
abdominal
bernhardt
level
frontier
2019
radiation
radiopeptide
com
deliver
theranostic
neurologic
closed
radiolabelled
result
statin
description
KA
120
185
processing
evaluate
but
EP
128
LP
only
local
MRI
between
baitz
conducting
beban
kesehat
engine
terbium
wen
mases
161tb
ben
siegel
below
rinne
firstly
resonance
soerjomataram
useful
multicenter
249
visual
tagged
schmidt
effect
lung
radio
number
166
gastrin
bandari
targeting
specialty
netherland
year
clin
untuk
biol
bakker
tolmachev
basel
barbato
MDPI
investigated
particle
frequently
labeled
food
obtain
related
jadvar
all
glu
RM26
rahbar
repository
along
182
present
regulatory
then
universita
NOTA
stability
world
patient
using
disorder
linker
commentarie
pattern
should
important
since
amino
tissue
weight
first
ACS
diagnosa
carrier
both
pharmacokinetic
filtered
sar
NP
carried
lymph
koester
alvarez
501
2006
DGA
radioisotope
performed
tract
RL
dose
supervision
419
chemotherapy
affinity
including
RGD
known
792
pharmacy
sabahnoo
direct
scientific
cheng
respectively
meanwhile
reduced
allow
mixed
candidate
overexpressing
variou
BAY86
some
undergo
develop
detect
reselected
radiopharmaceutical
power
ID
antagonist
saad
kanker
design
agonist
generator
article
cause
gmail
transfer
BBN7
criteria
vitro
7695
list
molecular
accurately
mail
MNP
chem
zeevaart
smith
2030
radioactively
roger
ımaging
nucl
internalization
malki
second
czepczynski
node
treat
pair
rep
pubmed
treatment
67cu
scanning
583309
2016
doeswijk
dengan
161
N4
haim
177lu
64cu
michaud
invade
PEG
7685
presented
newly
PEG3
purpose
radioactivity
PC
IL
available
brain
aharon
awaludin
yang
HR
meulen
tomography
zhou
umbricht
primary
december
clinical
gadot
radiotherapeutic
doctor
nurmaya
energy
7548
188re
evaluated
bray
increase
masss
maina
1930
our
more
simultaneously
tool
radiopeptida
under
severity
risk
january
diagnosi
pmol
JR
2012
need
give
tracer
PPMN
preclinical
perspective
68ga
ıncidence
explored
investigation
released
while
identification
expected
GLOBOCAN
currently
multi
diagnosed
pu
potential
uncontrollably
meta
without
200
PSMA
carrying
goe
million
kulkarni
lymperi
keamanan
chart
evidence
touijer
terminal
further
yap
park
identified
pharmaceutical
swenson
abouzayed
especially
oncol
small
muslim
86Y
administration
levartovsky
addition
meng
lutetium
rapidly
krenning
chimeric
containing
PJ
oedegaard
detection
contrast
nasution
recepto
september
jacobson
lang
alara
etc
SM
provide
bombesin
ED
BBN
section
177
namely
found
exces
burden
statement
MB1
285
CT
bioconjug
RI
weber
they
buletin
therapeutic
reporting
wa
breast
radionuclide
konijnenberg
agent
castration
2020
xenograft
better
1569
radiotheranostic
xia
keyword
eur
future
kossatz
kanellopoulo
chen
case
DB15
state
people
BA
acid
it
undertaken
grow
concentration
through
klette
vicrostatin
hand
212bi
2021
2022
revised
accumulation
ahmadzadehfar
211at
ABSTRACT
charged
cancer
based
theranosti
beta
kemeterian
radiolabeled
metastatic
CJ
617
two
velikyan
because
easily
conflict
DO3A
endocrine
deposition
2018
relevant
int
language
oncologist
great
disease
LET
estimated
received
asses
131I
uptake
urol
system
image
beattie
complexe
combination
health
RP
target
unit
developed
CONCLUSION
megabecquerel
fragment
outcome
synthesized
tschan
depend
interpretation
single
processe
accepted
iżycki
systematic
approved
menangani
studie
leibowitz
neuropeptide
1334
asa
estimate
gili
makassar
search
exhibited
secondly
response
bromińska
chose
mbq
reliable
locating
move
therapy
gracheva
marked
CA
maecke
225ac
almost
lyaschenko
interest
213bi
often
zhu
targeted
PET
also
quantitative
corresponding
not
ha
author
mainly
http
SU
among
commonly
fani
used
organ
pca
1575
emitted
orlandi
sex
exhibit
vincro
NE
18F
study
pharm
around
nuclear
prospective
99mtc
novel
type
use
distribution
SPECT
group
institutional
injected
diagnostic
time
called
davidson
wong
located
life
web
jong
sung
domachevsky
editorial
application
schehr
cyclotron
will
elsevier
eligible
full
new
death
neuron
research
find
out
aimed
non
neobo
singh
mediastinal
selection
literature
67ga
published
one
increasing
absorption
superior
gopalan
giarika